GLAZER CAPITAL, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
+182,925
(6.5%)
New positions
103
Sold out positions
53
Turnover %
138.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VRNA | 342,099 | NEW |
| CYBR | 164,484 | NEW |
| Merus N.V. | 152,464 | NEW |
| COOP | 86,828 | 240.5% |
| 89bio, Inc. | 82,863 | NEW |
| VBTX | 75,288 | NEW |
| WNS | 73,913 | NEW |
| VTY | 63,188 | NEW |
| PHLT | 52,231 | NEW |
| ZIMV | 43,456 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Enstar Group LTD | -242,516 | -100.0% |
| SpringWorks Therapeutics, Inc. | -193,038 | -100.0% |
| BPMC | -170,646 | -100.0% |
| DNB | -161,844 | -100.0% |
| SKAA | -151,041 | -100.0% |
| TRIUMPH GROUP INC | -97,646 | -100.0% |
| AZEK | -92,604 | -100.0% |
| MAG SILVER CORP | -91,035 | -100.0% |
| G | -82,081 | -100.0% |
| CHX | -61,215 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
939
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|